LS
MD icon

Livforsakringsbolaget Skandia’s Pediatrix Medical MD Stock Holding History

Livforsakringsbolaget Skandia’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,800
Closed -$78K – 711
2017
Q3 		$78K Hold
1,800
– – 0.01% 683
2017
Q2 		$109K Hold
1,800
– – 0.01% 647
2017
Q1 		$125K Sell
1,800
-2,000
-53% -$139K 0.01% 632
2016
Q4 		$253 Buy
3,800
+1,757
+86% +$114K 0.01% 642
2016
Q3 		$858K Sell
2,043
-8,457
-81% -$578K 0.04% 484
2016
Q2 		$761K Hold
10,500
– – 0.03% 495
2016
Q1 		$679K Hold
10,500
– – 0.03% 533
2015
Q4 		$752K Buy
+10,500
New +$777K 0.04% 496

Other funds holding MD

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BHG
Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

Livforsakringsbolaget Skandia's MD Position: Q4 2017 in Review

Livforsakringsbolaget Skandia sold out of Pediatrix Medical (MD) in Q4 2017, closing a stake of 1,800 shares — an estimated $78K sold.

Livforsakringsbolaget Skandia first reported a position in MD in Q4 2015 and held it in 8 quarters. The position peaked at $858K in Q3 2016. 330 funds tracked by Wall St. Rank hold MD as of Q4 2017.

  • Livforsakringsbolaget Skandia reported no remaining Pediatrix Medical position as of Q4 2017 after selling out during the quarter.
  • Livforsakringsbolaget Skandia sold 1,800 Pediatrix Medical shares in Q4 2017, an estimated $78K.
  • Livforsakringsbolaget Skandia first reported a position in Pediatrix Medical in Q4 2015 and held it in 8 quarters.
  • Livforsakringsbolaget Skandia's Pediatrix Medical position peaked at $858K in Q3 2016.
  • 330 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2017.

Based on Livforsakringsbolaget Skandia's 13F filing for Q4 2017, filed 18 Jan 2018.